Pharmacodynamics of isavuconazole in experimental invasive pulmonary aspergillosis: implications for clinical breakpoints

OBJECTIVES: Isavuconazole, a novel triazole antifungal agent, has broad-spectrum activity against Aspergillus spp. and other pathogenic fungi. The isavuconazole exposure–response relationship in experimental invasive pulmonary aspergillosis using galactomannan index (GMI) suppression as a marker of...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Antimicrob Chemother
Glavni autori: Kovanda, Laura L., Petraitiene, Ruta, Petraitis, Vidmantas, Walsh, Thomas J., Desai, Amit, Bonate, Peter, Hope, William W.
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2016
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4896411/
https://ncbi.nlm.nih.gov/pubmed/27084921
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkw098
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items